GXUS Among Gold ETFs
End-of-day Nov 19, 2026 · 29 Gold ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.5% | −5.9% | −7.6% | −11.2% | +4.8% | +9.0% | +53.4% | — | — | +49.4% |
| Peer average | −1.8% | −5.6% | −8.9% | −13.6% | −3.7% | +0.8% | +75.4% | +61.1% | +183.5% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$44 of every $1,000 in GXUS is Taiwan
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 2330.TWTaiwan Semiconductor MFG | Technology | 4.37% | $437.29 | 394K | $26.0M |
| 2 | 005930.KSSamsung Electronics | Technology | 1.83% | $183.06 | 77K | $10.9M |
| 3 | ASML.ASAsml | Technology | 1.43% | $142.55 | 6,230 | $8.5M |
| 4 | 000660.KSSK Hynix | Technology | 1.31% | $130.83 | 9,485 | $7.8M |
| 5 | ROP.SWRoche AG | Healthcare | 0.94% | $94.17 | 12K | $5.6M |
| 6 | HSBA.LHsbc | Financial Services | 0.82% | $81.92 | 280K | $4.9M |
| 7 | 0700.HKTencent Limited | Communication Services | 0.81% | $81.39 | 101K | $4.8M |
| 8 | NOVN.SWNovartis AG | Healthcare | 0.80% | $79.62 | 30K | $4.7M |
| 9 | SHEL.LShell | Energy | 0.77% | $77.24 | 95K | $4.6M |
| 10 | AZN.LAstrazeneca ORD | Healthcare | 0.76% | $75.64 | 25K | $4.5M |
| 11 | RY.TORoyal Bank OF Canada | Financial Services | 0.75% | $75.07 | 23K | $4.5M |
| 12 | NESN.SWNestle | Consumer Defensive | 0.74% | $73.53 | 42K | $4.4M |
| 13 | 8306.TMitsubishi UFJ Financial Group | Financial Services | 0.64% | $64.07 | 185K | $3.8M |
| 14 | SAP.DESAP SE | Technology | 0.63% | $62.83 | 17K | $3.7M |
| 15 | 9988.HKAlibaba Group Limited | Consumer Cyclical | 0.59% | $59.20 | 323K | $3.5M |
of the $259B in 46 Gold ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor MFG | 4.37% |
| 2 | 005930.KS | Samsung Electronics | 1.83% |
| 3 | ASML.AS | Asml | 1.43% |
| 4 | 000660.KS | SK Hynix | 1.31% |
| 5 | ROP.SW | Roche AG | 0.94% |
| 6 | HSBA.L | Hsbc | 0.82% |
| 7 | 0700.HK | Tencent Limited | 0.81% |
| 8 | NOVN.SW | Novartis AG | 0.80% |
| 9 | SHEL.L | Shell | 0.77% |
| 10 | AZN.L | Astrazeneca ORD | 0.76% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.49 |
| Jun 24, 2026 | Jun 30, 2026 | $0.56 |
| Mar 25, 2026 | Mar 31, 2026 | $0.17 |
| Dec 23, 2025 | Dec 30, 2025 | $0.38 |
| Sep 24, 2025 | Sep 30, 2025 | $0.33 |
| Jun 24, 2025 | Jun 30, 2025 | $0.52 |
| Mar 25, 2025 | Mar 31, 2025 | $0.25 |
| Dec 23, 2024 | Dec 30, 2024 | $0.22 |
| Sep 24, 2024 | Sep 30, 2024 | $0.49 |
| Jun 24, 2024 | Jun 28, 2024 | $0.44 |
| Mar 22, 2024 | Mar 28, 2024 | $0.10 |
| Dec 26, 2023 | Jan 2, 2024 | $0.21 |